A "POLARIZED ION" MODEL FOR LANTHANIDE TRIHALIDE MOLECULES.MYERS CE.1976; INORG. NUCL. CHEM. LETTERS; G.B.; DA. 1976; VOL. 12; NO 7; PP. 575-579; BIBL. 21 REF.Article

ANTITUMOR ANTIBIOTICS. I: ANTHRACYCLINESMYERS CE.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 51-68; BIBL. 78 REF.Article

VAPORIZATION BEHAVIOR OF COBALT PHOSPHIDES: THE SOLID TWO-PHASE REGIONS COP₃-COP AND COP-CO₂PMYERS CE.1974; HIGH TEMPER. SCI.; U.S.A.; DA. 1974; VOL. 6; NO 4; PP. 309-322; BIBL. 19 REF.Article

ATOMIZATION ENTHALPY OF EUROPIUM TRICHLORIDEMYERS CE.1975; INORG. CHEM.; U.S.A.; DA. 1975; VOL. 14; NO 8; PP. 2021-2022; BIBL. 6 REF.Article

VAPOR PRESSURES AND SUBLIMATION THERMODYNAMICS OF GDCL₃, TBCL₃ AND DYCL₃MYERS CE; HANNAY MH.1980; J. LESS-COMMON METALS; NLD; DA. 1980; VOL. 70; NO 1; PP. 15-24; BIBL. 22 REF.Article

SUBLIMATION PRESSURES AND THERMODYNAMICS OF PRASEODYNIUM TRICHLORIDEHANNAY MH; MYERS CE.1979; J. LESS-COMMON METALS; NLD; DA. 1979; VOL. 66; NO 2; PP. 145-150; BIBL. 13 REF.Article

VAPORIZATION THERMODYNAMICS OF LANTHANIDE TRIHALIDES.MYERS CE; GRAVES DT.1977; J. CHEM. ENGNG DATA; U.S.A.; DA. 1977; VOL. 22; NO 4; PP. 440-445; BIBL. 45 REF.Article

MEMBRANE - BOUND GLUTATHIONE PEROXIDASE - LIKE ACTIVITY IN MITOCHONDRIAKATKI AG; MYERS CE.1980; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1980; VOL. 96; NO 1; PP. 85-91; BIBL. 25 REF.Article

COMPLEX INHIBITION OF THYMIDYLATE SYNTHETASE BY AROMATIC DIAMIDINES: EVIDENCE FOR BOTH RAPID, FREELY REVERSIBLE AND SLOWLY PROGRESSIVE, NONEQUILIBRIUM INHIBITION.KAPLAN HG; MYERS CE.1977; J. PHARMACOL. EXP. THERAPEUT.; U.S.A.; DA. 1977; VOL. 201; NO 3; PP. 554-563; BIBL. 1 P. 1/2Article

ANALYSIS OF CYTIDINE DEAMINASE AND TETRAHYDROURIDINE INTERACTION BY USE OF LIGAND TECHNIQUES.STOLLER RG; MYERS CE; CHABNER BA et al.1978; BIOCHEM. PHARMACOL.; G.B.; DA. 1978; VOL. 27; NO 1; PP. 53-59; BIBL. 23 REF.Article

VAPORIZATION BEHAVIOR OF MNP(S) AND THE THERMODYNAMICS OF THE MANGANESE-PHOSPHORUS SYSTEMMYERS CE; JUNG ED; PATTERSON EL et al.1980; INORG. CHEM.; USA; DA. 1980; VOL. 19; NO 2; PP. 532-534; BIBL. 20 REF.Article

NEW DEVELOPMENTS ON THE MECHANISMS OF ACTION OF ANTINEOPLASTIC DRUGSDONEHOWER RC; MYERS CE; CHABNER BA et al.1979; LIFE SCI.; GBR; DA. 1979; VOL. 25; NO 1; PP. 1-13; BIBL. 84 REF.Article

MODE OF ACTION OF 5-FLUOROCYTOSINE.DIASIO RB; BENNETT JE; MYERS CE et al.1978; BIOCHEM. PHARMACOL.; G.B.; DA. 1978; VOL. 27; NO 5; PP. 703-707; BIBL. 20 REF.Article

BIOCHEMICAL DETERMINANTS OF 5-FLUOROURACIL RESPONSE IN VIVO.MYERS CE; YOUNG RC; CHABNER BA et al.1975; J. CLIN. INVEST.; U.S.A.; DA. 1975; VOL. 56; NO 5; PP. 1231-1238; BIBL. 25 REF.Article

COMPETITIVE PROTEIN BINDING ASSAY OF METHOTREXATEERLICHMAN C; DONEHOWER RC; MYERS CE et al.1982; METHODS ENZYMOL.; ISSN 0076-6879; USA; DA. 1982; VOL. 84; PP. 447-458; BIBL. 22 REF.Article

EXPERIMENTAL ANIMAL MODELS OF ADRIAMYCIN CARDIOTOXICITYDOROSHOW JH; LOCKER GY; MYERS CE et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 855-860; BIBL. 42 REF.Article

DETERMINATION OF THE ATOMIZATION ENERGIES OF THE MOLECULES TAO(G) AND TAO₂(G) BY THE MASS-SPECTROMETRIC KNUDSEN-CELL METHODSMOES S; DROWART J; MYERS CE et al.1976; J. CHEM. THERMODYNAM.; G.B.; DA. 1976; VOL. 8; NO 3; PP. 225-239; BIBL. 31 REF.Article

KINETIC ALTERATIONS INDUCED BY 5-FLUOROURACIL IN BONE MARROW, INTESTINAL MUCOSA, AND TUMORMYERS CE; YOUNG RC; CHABNER BA et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 5; PP. 1653-1658; BIBL. 17 REF.Article

EVALUATION OF WEEKLY ESCALATING DOSES OF DICHLOROMETHOTREXATE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND OTHER SOLID TUMORSTESTER WJ; DONEHOWER RC; EDDY JL et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 3; PP. 305-310; BIBL. 20 REF.Article

OXIDATIVE DESTRUCTION OF ERYTHROCYTE GHOST MEMBRANES CATALYZED BY THE DOXORUBICIN-IRON COMPLEXMYERS CE; GIANNI L; SIMONE CB et al.1982; BIOCHEMISTRY (EAST.); ISSN 0006-2960; USA; DA. 1982; VOL. 21; NO 8; PP. 1707-1713; BIBL. 28 REF.Article

THE EFFECT OF DOXORUBICIN ON HEPATIC AND CARDIAC GLUTATHIONEDOROSHOW JH; LOCKER GY; BALDINGER J et al.1979; RES. COMMUNIC. CHEM.- PATHOL. PHARMACOL.; USA; DA. 1979; VOL. 26; NO 2; PP. 285-295; BIBL. 2 P.Article

REVERSIBILITY OF HIGH-AFFINITY BINDING OF METHOTREXATE IN L1210 MURINE LEUKEMIA CELLSCOHEN M; BENDER RA; DONEHOWER R et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 9; PP. 2866-2870; BIBL. 18 REF.Article

THE CLINICAL PHARMACOLOGY OF ANTINEOPLASTIC AGENTS. (SECOND OF TWO PARTS) = PHARMACOLOGIE CLINIQUE DES PRODUITS ANTICANCEREUX. DEUXIEME ET DERNIERE PARTIECHABNER BA; MYERS CE; COLEMAN N et al.1975; NEW ENGL. J. MED.; U.S.A.; DA. 1975; VOL. 292; NO 22; PP. 1159-1168; BIBL. 1P.1/2Article

PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN THE TREATMENT OF OVARIAN CANCER.DEDRICK RL; MYERS CE; BUNGARY PM et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 1-11; BIBL. 24 REF.Article

BONE MARROW INVOLVEMENT IN HODGKIN'S DISEASE: PATHOLOGY AND RESPONSE TO MOPP CHEMOTHERAPY = ATTEINTE DE LA MOELLE OSSEUSE DANS LA MALADIE DE HODGKIN: PATHOLOGIE ET REPONSE A LA CHIMIOTHERAPIE MOPPMYERS CE; CHABNER BA; DE VITA VT et al.1974; BLOOD; U.S.A.; DA. 1974; VOL. 44; NO 2; PP. 197-204; BIBL. 16REF.Article